New options may be possible for treatment-resistant and severe rosacea with the use of IL-17 inhibitors as researchers conduct studies on effectiveness.
Dr. Day presents her best tips on approaching social media channels as a tool to engage with potential patients, knowing your audience and sharing the latest science and trends in dermatology.
Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.
Dr. Torres explores continuing medical education programs and whether they're successful in helping physicians obtain new knowledge.
Study shows measurement of early ustekinumab levels could be used to direct treatment strategy in psoriasis.
Niki Vora reflects on how her struggles with untreated atopic dermatitis, folliculitis and cystic acne led her to writing her scholarship-winning essay.
The Prior Authorizations process creates inconsistent application, physician dissatisfaction and opportunity for life-threatening adverse events for patients.
In this Legal Eagle article, Dr. Goldberg discusses the intricacies of the physician-patient relationship, and how that relationship can still be formed even if you never see the patient.
The methods and products used to combat the day-to-day impacts of melasma has expanded to include tranexamic acid, cysteamine, along others.
New research has shed light on how hyperpigmentation occurs. Experts break down what you need to know in this article.